Close
Blog & Resources Camargo Blog July 2nd, 2008

Orphan’s Turn 25

I attended a session at the 2008 BIO convention in San Diego celebrating the 25th anniversary of the Orphan Drug Act. Before the Act, there were almost no orphan drugs. The exemption from the PDUFA user fees (running $1.175MM today), 50% tax credit for clinical studies and a 7 year marketing exclusivity are powerful incentives to develop these drugs. Tim Coté, Division Director, noted that the Agency has about $14MM ijn grants per year and has not used up the money. Time to write your grant and get free government money!


Categories: Orphan Drug

Get Our Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our solutions or contact us.


Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.


Contact
Headquarters
9825 Kenwood Road,
Suite 203
Cincinnati, OH 45242
Durham Office
2505 Meridian Parkway,
Suite 150
Durham, NC 27713
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights